PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Marco Chierici Paolo Romania Ombretta Melaiu Doriana Fruci Tao Liu |
| Publication date | March 7, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |